The initial infection that caused a regular cold would create T cells, which would then be able to recognize the novel coronavirus and accelerate the immune response against COVID-19.
Before that, a study showed that neutralizing antibodies produced after infection with SARS-CoV-2 would vanish from the immune system, prompting some to worry that reinfection might be possible within a short time.
Some of the vaccine candidates that have reached the final stage of clinical trials have induced both neutralizing antibodies and T cell responses in volunteers, which is a promising development for long-lasting immunity.
Anthony Fauci addressed the new study that explained how common colds could induce COVID-19 immunity, explaining coronavirus immunity the way it should have been done from the start.
Fauci said of the new study that it could explain why some people have no COVID-19 symptoms after being infected, while others need hospitalization and risk death.
A virologist at Columbia University used the same army analogy to differentiate the neutralizing antibodies from the T cells that can both kill infected cells and initiate the production of more antibodies.